Vanda Pharmaceuticals Reports Third-Quarter Revenue of $69.8 Million
Story updates
08:01:53 PM UTC
SquawkNews
WASHINGTON, Oct. 28, 2026 // -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ended September 30, 2026."We are pleased with the strong revenue growth in the third quarter, increasing 24% year-over-year, driven by…
08:05:58 PM UTC
SquawkNews
Q3 2026 Total Revenues increased 24% to $69.8 million compared to Q3 2025 and 38% compared to Q2 202
08:06:42 PM UTC
SquawkNews
VANDA PHARMACEUTICALS Q3 REVENUE USD 69.815 MILLION VS. IBES ESTIMATE USD 69.2 MILLION
08:19:54 PM UTC
SquawkNews
Vanda Pharmaceuticals Q3 revenue up 24% driven by Fanapt sales
08:20:10 PM UTC
SquawkNews
Vanda Pharmaceuticals Q3 revenue up 24% driven by Fanapt sales Overview Biopharma firm's Q3 revenue
08:30:54 PM UTC
SquawkNews
BRIEF-Vanda Pharmaceuticals Reports Third Quarter 2026 Financial Results Oct 28 (Reuters) - Vanda Ph